At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 50 enrolled
Drug / intervention
Conivaptan +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase IIIb, Randomized, Double-Blind, Parallel Group, Multi-Center, Study to Assess the Efficacy and Safety of Multiple 30 Minute Infusions of YM087 (Conivaptan) in Subjects With Euvolemic or Hypervolemic Hyponatremia
In Brief
A Phase 3 clinical trial evaluating Conivaptan and Placebo for Hyponatremia. Completed, enrolled 50 participants across 26 sites in 2 countries.
Detailed Summary
The study is designed to assess the efficacy and safety of multiple infusions of conivaptan in subjects with euvolemic or hypervolemic hyponatremia
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyponatremia
CountriesIndia, United States
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedMay 2007
Primary CompletionAug 2008
TodayJul 2026
First PostedMay 24, 2007
Enrollment StartApr 1, 2007
Primary CompletionAug 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 19.1 years ago
Interventions
Conivaptandrug
premix bag
Placebodrug
premix bag